Gender: n (%) |
Male |
0 |
4 (10.5) (95% CI: 4.2–24.1) |
P > 0.05 |
Female |
32 (100) (95% CI: 89.3–100) |
34 (89.5) (95% CI: 7.6–95.8) |
Age (Mean ± SD; year) |
38.3 ± 11.3 (95% CI: 34.2–42.4) |
46.7 ± 10.9 (95% CI: 43.1–50.3) |
P < 0.05 |
Pathology: n (%) |
Benign nodule |
31 (96.9) (95% CI: 84.3–99.5) |
38 (100) (95% CI: 90.8–100) |
P > 0.05 |
Micropapillary carcinoma |
1 (3.1) (95% CI: 0.6–15.7) |
0 |
Nodule size (Mean ± SD; cm) |
2.8 ± 1.2 (95% CI: 2.4–3.2) |
3.4 ± 1.2 (95% CI: 3.0–3.8) |
P < 0.05 |
Operative time (Mean ± SD; min) |
123.8 ± 26.3 (95% CI: 114.3–133.3) |
84.1 ± 35.5 (95% CI: 72.4–95.8) |
P < 0.05 |
Blood loss (Mean ± SD; cc) |
23.9 ± 46.2 (95% CI: 7.2–40.6) |
24.2 ± 29.0 (95% CI: 14.7–33.7) |
P > 0.05 |
Hospital stay (Mean ± SD; day) |
3.3 ± 0.7 (95% CI: 3.1–3.6) |
3.4 ± 0.8 (95% CI: 3.1–3.7) |
P > 0.05 |
Complication: n (%) |
Vocal cord paresis |
3 (9.3) (95% CI: 3.2–24.2) |
1 (2.6) (95% CI: 0.4–13.4) |
P > 0.05 |
Vocal cord paralysis |
1 (3.1) (95% CI: 0.6–15.7) |
1 (2.6) (95%CI: 0.4–13.4) |
P > 0.05 |
Surgical site infection |
0 |
0 |
P > 0.05 |